These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4182817)

  • 1. Pentazocine addiction?
    Mungavin JM
    Lancet; 1969 Jul; 2(7610):56-7. PubMed ID: 4182817
    [No Abstract]   [Full Text] [Related]  

  • 2. Pentazocine abuse rises--Schedule IV status proposed.
    FDA Drug Bull; 1978 Dec-1979 Jan; 8(6):34. PubMed ID: 720788
    [No Abstract]   [Full Text] [Related]  

  • 3. Pentazocine dependency.
    Parwatikar S; Gomez H; Knowles RR
    Int J Addict; 1973; 8(1):87-98. PubMed ID: 4713708
    [No Abstract]   [Full Text] [Related]  

  • 4. The misuse of pentazocine. Its dependence-producing potential.
    JAMA; 1969 Sep; 209(10):1518-9. PubMed ID: 5820108
    [No Abstract]   [Full Text] [Related]  

  • 5. Pain and pentazocine: problems of control.
    Still CN
    South Med J; 1975 Jul; 68(7):805-7. PubMed ID: 1098156
    [No Abstract]   [Full Text] [Related]  

  • 6. Abuse of pentazocine.
    Kubicki S
    Br Med J; 1978 Sep; 2(6142):955-6. PubMed ID: 709150
    [No Abstract]   [Full Text] [Related]  

  • 7. Benzodiazepines and pentazocine scheduled under convention on psychotropic substances.
    Lancet; 1984 Mar; 1(8377):637. PubMed ID: 6142346
    [No Abstract]   [Full Text] [Related]  

  • 8. Misprescribing analgesics.
    Lewis JR
    JAMA; 1974 May; 228(9):1155-6. PubMed ID: 4406445
    [No Abstract]   [Full Text] [Related]  

  • 9. STUDIES ON THE HUMAN ADDICTION LIABILITY OF 2'-HYDROXY-5-9-DIMETHYL-2-(3,3-DIMETHYLALLYL)-6,7-BENZOMORPHAN (WIN 20,228): A WEAK NARCOTIC ANTAGONIST.
    FRASER HF; ROSENBERG DE
    J Pharmacol Exp Ther; 1964 Feb; 143():149-56. PubMed ID: 14163986
    [No Abstract]   [Full Text] [Related]  

  • 10. Pentazocine (Talwin).
    Med Lett Drugs Ther; 1969 May; 11(10):41-2. PubMed ID: 5787904
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of Talwin NX.
    Senay EC; Clara JR
    NIDA Res Monogr; 1984; 55():170-7. PubMed ID: 6443375
    [No Abstract]   [Full Text] [Related]  

  • 12. [Toxicomanogenic properties of derivatives of dextromorphan].
    La Barre J
    Therapie; 1970; 25(3):565-78. PubMed ID: 5431848
    [No Abstract]   [Full Text] [Related]  

  • 13. DERELICTIONS OF THE MEDICAL PROFESSION CONCERNING NARCOTIC ADDICTION.
    STOKES RC
    Tex State J Med; 1963 Sep; 59():839-42. PubMed ID: 14050481
    [No Abstract]   [Full Text] [Related]  

  • 14. PENTAZOCINE--A NEW NONADDICTING ANALGESIC. PRELIMINARY SINGLE-BLIND STUDY.
    SADOVE M; BALAGOT RC; PECORA FN
    JAMA; 1964 Jul; 189():199-202. PubMed ID: 14150002
    [No Abstract]   [Full Text] [Related]  

  • 15. Addiction to pentazocine: report of two cases.
    Weber WF; Frome HP
    JAMA; 1970 Jun; 212(10):1708. PubMed ID: 5467857
    [No Abstract]   [Full Text] [Related]  

  • 16. Pentazocine addiction?
    Schoolar JC; Idänpään-Heikkilä P; Keats AS
    Lancet; 1969 Jun; 1(7608):1263. PubMed ID: 4182432
    [No Abstract]   [Full Text] [Related]  

  • 17. The convention on psychotropic substances: why it should be ratified.
    Rosen JA
    J Leg Med (N Y); 1974; 2(3):44-7. PubMed ID: 4546226
    [No Abstract]   [Full Text] [Related]  

  • 18. Cutaneous manifestations of pentazocine addiction.
    Cosman B
    JAMA; 1978 Jan; 239(5):404. PubMed ID: 621836
    [No Abstract]   [Full Text] [Related]  

  • 19. Abuse of pentazocine-naloxone combination.
    Reed DA; Schnoll SH
    JAMA; 1986 Nov; 256(18):2562-4. PubMed ID: 3773159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The narcotics. Latest accomplishments at the United Nations].
    Vaille C
    Presse Med (1893); 1971 Nov; 79(51):2333-5. PubMed ID: 5129479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.